Stay updated on Filgotinib and Lanraplenib in Female CLE Clinical Trial

Sign up to get notified when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Filgotinib and Lanraplenib in Female CLE Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    The changes appear to be cosmetic: the page's layout/formatting has been updated, but there is no visible modification to core study details such as title, objectives, design, outcomes, eligibility criteria, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-28T05:20:22.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    4%
    Check dated 2025-10-06T16:10:45.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T10:14:24.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; the 'Back to Top' navigation item has been removed. No substantive content changes were detected.
    Difference
    0.2%
    Check dated 2025-09-15T02:41:36.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T23:00:43.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several terms related to diseases and previous location details have been removed.
    Difference
    2%
    Check dated 2025-08-31T19:56:59.000Z thumbnail image

Stay in the know with updates to Filgotinib and Lanraplenib in Female CLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib and Lanraplenib in Female CLE Clinical Trial page.